Literature DB >> 25864505

Ethical dilemmas, work-related guilt, and posttraumatic stress reactions of news journalists covering the terror attack in Norway in 2011.

Klas Backholm1, Trond Idås.   

Abstract

News journalists working on crisis-related assignments may experience dilemmas with regard to how to conduct their work without causing additional harm to first-hand victims. In this study, we investigated how exposure to journalistic ethical dilemmas during the Oslo/Utøya terror attack in 2011 and subsequent work-related guilt were related to the development of posttraumatic stress (PTS) reactions. Norwegian journalists (N = 371) covering the terror attack participated in a web-based survey 8-9 months after the incident. We found that females reported more ethical dilemmas during the assignment than males (n = 356, d = 0.51). We also found that being on the scene was not related to more exposure to dilemmas (n = 311, d = 0.01). Moreover, we discovered that work-related guilt had a significant indirect effect on the relationship between exposure to ethical dilemmas and severity of PTS reactions (n = 344, completely standardized indirect effect size = .11, 95% CI [.04, .19]. The results showed that exposure to ethical dilemmas may affect the development of long-term psychological impairment. We concluded that media organizations can prevent postcrisis impairment by preparing employees for possible exposure to dilemmas during crisis-related assignments.
Copyright © 2015 Wiley Periodicals, Inc., A Wiley Company.

Entities:  

Mesh:

Year:  2015        PMID: 25864505     DOI: 10.1002/jts.22001

Source DB:  PubMed          Journal:  J Trauma Stress        ISSN: 0894-9867


  2 in total

Review 1.  News Journalists and Postruamatic Stress Disorder: a Review of Literature, 2011-2020.

Authors:  Raymond B Flannery
Journal:  Psychiatr Q       Date:  2021-04-10

Review 2.  Cognitive therapy for moral injury in post-traumatic stress disorder.

Authors:  Hannah Murray; Anke Ehlers
Journal:  Cogn Behav Therap       Date:  2021-01-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.